“…() found that youth with a lifetime diagnosis of an externalising disorder showed lower levels of NR3C1 methylation at exon 1F (whole blood), compared with both youth with a depressive disorder and healthy controls. Based on data extracted from white blood cells, one research group also found that, compared with controls, adult males with a history of chronic childhood aggression differed in (a) SLC6A4 promoter methylation and in vivo levels of brain serotonin synthesis (Wang et al., ); (b) DNAm levels in a set of genes involved in cytokine function and inflammation (Provençal, Suderman, Vitaro, Szyf, & Tremblay, ); and (c) DNAm patterns across a large number of gene promoter regions in an epigenome‐wide scan (Provençal et al., ) – a finding that was later extended to a small sample of adult females as well (Guillemin et al., ). In the ALSPAC sample, we found that methylomic variation at seven loci across the genome at birth (cord blood) differentiated children who go on to develop early‐onset ( n = 174) versus low ( n = 86) conduct problems, including sites in the vicinity of MGLL – a gene involved in endocannabinoid signalling and pain perception (Cecil, et al., ).…”